Press Coverage
Law Firms Predict More Growth in Healthcare M&A, Digital Health
April 9, 2025
Go Back to Health Care + Life Sciences
Industry
Digital Health
In the post-pandemic era, digital health technologies will continue to play a critical role in connecting patients to quality care and their data, and in obtaining better health outcomes.
We understand the complex legal and regulatory issues related to the development and use of digital health tools, including telehealth/telemedicine, mobile medical apps, wearable devices, health information technology (HIT), digital therapeutics, AI, and data analytics. Our Digital Health team helps clients on all fronts as technology revolutionizes the delivery of health care.
Our holistic approach examines the privacy, security, regulatory, IP, and liability risk factors of each client’s policies, products, and services. This background informs the work we do in helping our clients bring effective and compliant products and services to market. Work we handle includes:
- Advice on the legal and governance infrastructure needed to support interoperability.
- Negotiation and execution of complex digital health technology contracts, including software development and licensing agreements, data hosting agreements, data sharing, and data use agreements.
- Regulatory compliance advice, including how to navigate federal health IT certification requirements; FDA regulations; and guidance on the use of scientific and medical data in clinical trials and other initiatives.
- Cybersecurity and privacy advice, including development and implementation of policies and procedures; advising on compliance with HIPAA, FDA, and FTC regulations related to data usage; and investigating and responding to data breaches and other incidents.
- Venture capital and private equity transactions involving promising new companies and technologies.
- IP counseling on acquiring, developing, generating, and protecting proprietary content, databases, and mobile app platforms, devices, and data.
Our highest goal? Achieving yours.
Exceptional results are our best practice
Find your professional
This just in
Articles + Publications
A Model’s Credibility Is in the Details: FDA Draft Guidance on the Use of AI Models in Drug and Biological Product Development
February 12, 2025
Articles + Publications
Q4 2024 Health Care Conference Roundup: AI and Government Enforcement Are on the Rise
January 9, 2025
Podcasts
AI and Pharmacovigilance Under the FDA’s New Emerging Drug Safety Technology Program
December 11, 2024